Amgen reiterated by Bear Stearns at peer perform

Amgen Inc. was reiterated by Bear Stearns analyst Mark Schoenebaum at a peer perform rating. Bear Stearns' short-term bias on the stock remains positive as the base business is strong and pipeline quality and visibility is improving, but looking to late 2005 and early 2006, the firm believes the stock could cool when news flow around potential competition intensifies. Amgen shares Friday were up $1.28, or 1.53%, at $84.86 on volume of 9,841,037 shares versus the three-month running average of 9,820,080 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.